Not applicableUnknownNCT00553215What this trial is testingQuality of Life in Patients With Bladder CancerWho this might be right forBladder Cancer University of Birmingham 2,700
Large-scale testing (Phase 3)Study completedNCT00445601What this trial is testingS0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder CancerWho this might be right forBladder Cancer SWOG Cancer Research Network 406
Large-scale testing (Phase 3)Study completedNCT00729287What this trial is testingSelenium in Preventing Cancer Recurrence in Patients With Bladder CancerWho this might be right forBladder Cancer KU Leuven 276
Not applicableWithdrawnNCT02252393What this trial is testingUrinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder CancerWho this might be right forRecurrent Bladder CancerStage 0 Bladder CancerStage I Bladder Cancer+2 more Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00047216What this trial is testingTipifarnib in Treating Patients With Recurrent Bladder CancerWho this might be right forBladder Cancer University Health Network, Toronto
Large-scale testing (Phase 3)UnknownNCT00553124What this trial is testingDifferent Factors Affecting Patients With Newly Diagnosed Bladder CancerWho this might be right forBladder Cancer University Hospital Birmingham 3,400
Large-scale testing (Phase 3)Ended earlyNCT00352079What this trial is testingBCG With or Without Gefitinib in Treating Patients With High-Risk Bladder CancerWho this might be right forBladder Cancer NCIC Clinical Trials Group 41
Very early researchEnded earlyNCT01245660What this trial is testingOf Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before CystectomyWho this might be right forBladder CarcinomaInfiltrative Bladder CarcinomaCystectomy University Hospital, Bordeaux 3
Testing effectiveness (Phase 2)Study completedNCT00002917What this trial is testingPaclitaxel in Treating Patients With Early-Stage Bladder CancerWho this might be right forBladder Cancer Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Testing effectiveness (Phase 2)Study completedNCT00003129What this trial is testingChemotherapy in Treating Patients With Early-Stage Bladder CancerWho this might be right forBladder Cancer Eastern Cooperative Oncology Group 75
Testing effectiveness (Phase 2)Study completedNCT00023842What this trial is testingBCG With or Without Mitomycin in Treating Patients With Bladder CancerWho this might be right forBladder Cancer European Organisation for Research and Treatment of Cancer - EORTC 97
Large-scale testing (Phase 3)UnknownNCT00003725What this trial is testingSurgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder CancerWho this might be right forBladder Cancer Anthra Pharmaceuticals 300
Large-scale testing (Phase 3)Study completedNCT00002990What this trial is testingSurgery and BCG in Treating Patients With Bladder CancerWho this might be right forBladder Cancer European Organisation for Research and Treatment of Cancer - EORTC 1,288
Early research (Phase 1)Study completedNCT00006476What this trial is testingSuramin in Treating Patients With Recurrent Bladder CancerWho this might be right forBladder Cancer Cancer Research UK 15
Not applicableEnded earlyNCT01108003What this trial is testingBroccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing SurgeryWho this might be right forRecurrent Bladder CancerStage 0 Bladder CancerStage I Bladder Cancer+2 more Roswell Park Cancer Institute 7
Large-scale testing (Phase 3)Study completedNCT00003814What this trial is testingEflornithine in Treating Patients With Bladder CancerWho this might be right forBladder Cancer National Cancer Institute (NCI) 450
Large-scale testing (Phase 3)Study completedNCT00006034What this trial is testingKeyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder CancerWho this might be right forBladder Cancer Intracel
Large-scale testing (Phase 3)Study completedNCT01442519What this trial is testingSequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder CancerWho this might be right forBladder Cancer University of Rome Tor Vergata 212
Large-scale testing (Phase 3)UnknownNCT00553345What this trial is testingSelenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder CancerWho this might be right forBladder Cancer University of Birmingham 515
Large-scale testing (Phase 3)UnknownNCT01094964What this trial is testingHyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder CancerWho this might be right forBladder Cancer Cancer Research Campaign Clinical Trials Centre 242